Therefore, the expression of both LAMP‐1 and LAMP‐2 on NK cells in CFS/ME patients may be an indicator of the cytotoxic capacity of the cells, and the immune status of the patients. This evidence concerns the gene LAMP1 and myalgic encephalomeyelitis/chronic fatigue syndrome.